Welcome!
Pharmaceutical Industry
Broker's Calls
KGI gives Hyphens a ‘buy', saying 'skin is the game'
KGI is initiating coverage on Hyphens Pharma with an “outperform” call and a target price of 48 cents.
November 10, 2020
Broker's Calls
There are more opportunities to profit from global markets now: Citi
Diversified asset allocation from dividends and certain fixed income substitutes can help investors capitalise on low rates.
September 21, 2020
Healthcare
Hyphens Pharma enjoys lift from broader product range and wider distribution channels
Hyphens’ CFO Fang Lee Wei sayS the counter was “under-recognised and severely undervalued” in its first 18 months since listing.
September 11, 2020
Singapore economy
Panic buying medicine to benefit Singapore pharmaceutical exports
Covid-19 caused panic buying in the pharmaceutical industry and Singapore is benefitting
August 28, 2020